In this study, we serendipitously discovered the inhibitory activity of the broad-spectrum CoV fusion inhibitors EK1 and EK1V1 against HIV-1 infection in terms of viral Env-mediated cell–cell fusion and pseudovirus infection. The gene discussed is ERVW-1; the disease is HIV-1 infection.